We are live on ! Find out more
BCRX icon

BioCryst Pharmaceuticals
BCRX

134 hedge funds and large institutions have $245M invested in BioCryst Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

671% more call options, than puts

Call options by funds: $3.05M | Put options by funds: $396K

37% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 38

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 136 → 134 (-2)

9.59% less ownership

Funds ownership: 89.1% → 79.51% (-9.6%)

48% less capital invested

Capital invested by funds: $473M → $245M (-$228M)

Holders
134
Holders Change
-2
Holders Change %
-1.47%
% of All Funds
2.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
52
Reduced
38
Closed
25
Calls
$3.05M
Puts
$396K
Net Calls
+$2.66M
Net Calls Change
+$1.39M

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.64M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$8.28M
3
EP
Eversept Partners
New York
+$7.26M
4
Stifel Financial
Stifel Financial
Missouri
+$5.76M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.5M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$14.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$12.5M
3
Millennium Management
Millennium Management
New York
-$9.6M
4
PVI
Pura Vida Investments
New York
-$7.52M
5
ACP
Acuta Capital Partners
California
-$7.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
BFEC
126
Benjamin F. Edwards & Company
Missouri
$2K – – –
Daiwa Securities Group
127
Daiwa Securities Group
Japan
$2K – – –
MAM
128
Meeder Asset Management
Ohio
$2K +$1.15K +416 +69%
FMTCOCP
129
Farmers & Merchants Trust Co of Chambersburg PA
Pennsylvania
$1K – – –
FHA
130
Flagship Harbor Advisors
Massachusetts
$1K – – –
IFAM
131
Institutional & Family Asset Management
Colorado
$1K – – –
SAM
132
S.A. Mason
Michigan
$1K – – –
PVI
133
Pura Vida Investments
New York
– -$7.52M -2,179,950 Closed
MS
134
Maven Securities
Jersey
– -$3.65M -1,118,593 Closed
Renaissance Technologies
135
Renaissance Technologies
New York
– -$2.9M -840,734 Closed
Canada Pension Plan Investment Board
136
Canada Pension Plan Investment Board
Ontario, Canada
– -$2.58M -749,200 Closed
SSA
137
Schonfeld Strategic Advisors
New York
– -$1.37M -397,266 Closed
CH
138
CVI Holdings
Delaware
– -$514K -148,952 Closed
NAM
139
Nexpoint Asset Management
Texas
– -$397K -115,000 Closed
Ameriprise
140
Ameriprise
Minnesota
– -$377K -109,019 Closed
Ohio Public Employees Retirement System (OPERS)
141
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$263K -76,200 Closed
Assenagon Asset Management
142
Assenagon Asset Management
Luxembourg
– -$258K -74,744 Closed
Schroder Investment Management Group
143
Schroder Investment Management Group
United Kingdom
– -$191K -55,420 Closed
Public Sector Pension Investment Board (PSP Investments)
144
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$168K -48,801 Closed
BFM
145
Boothbay Fund Management
New York
– -$104K -30,000 Closed
QIM
146
Quantitative Investment Management
Virginia
– -$85K -24,704 Closed
Man Group
147
Man Group
United Kingdom
– -$84K -24,300 Closed
Wellington Management Group
148
Wellington Management Group
Massachusetts
– -$78K -22,708 Closed
VRS
149
Virginia Retirement Systems
Virginia
– -$58K -16,900 Closed
Qube Research & Technologies (QRT)
150
Qube Research & Technologies (QRT)
United Kingdom
– -$51K -14,836 Closed
3 4 5
6
7

BCRX Hedge Fund Activity: Q1 2020 in Review

134 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in BioCryst Pharmaceuticals (BCRX) for Q1 2020, worth a combined $245M — down 48% from $473M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BCRX positions and 25 closed out — a net gain of 1 holder — while 52 added to existing stakes and 38 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $9.64M. The largest seller was Point72 Asset Management, cutting an estimated $14.8M.

  • 134 institutional investors held BioCryst Pharmaceuticals (BCRX) as of Q1 2020, down from 136 in Q4 2019.
  • Funds reported $245M of BioCryst Pharmaceuticals stock for Q1 2020, down 48% quarter-over-quarter.
  • 26 funds opened new BioCryst Pharmaceuticals positions in Q1 2020 and 25 closed out, a net change of +1 holder.
  • The largest BioCryst Pharmaceuticals buyer in Q1 2020 was Adage Capital Partners, an estimated $9.64M added.
  • The largest BioCryst Pharmaceuticals seller in Q1 2020 was Point72 Asset Management, an estimated $14.8M sold.

Based on aggregated 13F filings for Q1 2020.